BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 33255345)

  • 1. Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia.
    Aquila G; Re Cecconi AD; Brault JJ; Corli O; Piccirillo R
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
    Saitoh M; Ishida J; Doehner W; von Haehling S; Anker MS; Coats AJS; Anker SD; Springer J
    Int J Cardiol; 2017 Jul; 238():5-11. PubMed ID: 28427849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.
    Dave S; Patel BM
    Fundam Clin Pharmacol; 2023 Dec; 37(6):1079-1091. PubMed ID: 37474262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations.
    Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F
    FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle Atrophy in Cancer.
    Yang J; Cao RY; Li Q; Zhu F
    Adv Exp Med Biol; 2018; 1088():329-346. PubMed ID: 30390259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.
    Holeček M
    J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):529-541. PubMed ID: 28493406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects.
    Mavropalias G; Sim M; Taaffe DR; Galvão DA; Spry N; Kraemer WJ; Häkkinen K; Newton RU
    J Cancer Res Clin Oncol; 2022 Jun; 148(6):1389-1406. PubMed ID: 35088134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.
    Vitorino R; Moreira-Gonçalves D; Ferreira R
    Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):226-33. PubMed ID: 25783794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.
    Khamoui AV; Kim JS
    Eur J Cancer Care (Engl); 2012 Mar; 21(2):143-57. PubMed ID: 21880081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
    Daou HN
    Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting.
    Wyart E; Reano S; Hsu MY; Longo DL; Li M; Hirsch E; Filigheddu N; Ghigo A; Riganti C; Porporato PE
    Oxid Med Cell Longev; 2018; 2018():6419805. PubMed ID: 29682162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathophysiology of cachexia in chronic obstructive pulmonary disease.
    Schols AM; Gosker HR
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
    Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
    Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting.
    Huot JR; Baumfalk D; Resendiz A; Bonetto A; Smuder AJ; Penna F
    Antioxid Redox Signal; 2023 Feb; 38(4-6):352-370. PubMed ID: 36310444
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
    Arneson PC; Doles JD
    Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of muscle wasting in cancer: what is the future?
    Muscaritoli M; Bossola M; Bellantone R; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):459-66. PubMed ID: 15192450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.
    Okutsu M; Call JA; Lira VA; Zhang M; Donet JA; French BA; Martin KS; Peirce-Cottler SM; Rembold CM; Annex BH; Yan Z
    Circ Heart Fail; 2014 May; 7(3):519-30. PubMed ID: 24523418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):619-32. PubMed ID: 19860537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Etiology and Impact of Muscle Wasting in Metastatic Cancer.
    Biswas AK; Acharyya S
    Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31615873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.